A stealthy biotechnology startup has agreed to pay potentially hundreds of millions of dollars for an experimental medicine from Fosun Pharma, adding to a flurry of dealmaking involving drugs ...

With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial ...

A regimen involving the company’s shot failed a Phase 3 trial “by a hair,” an executive said, leading the company to believe ...